This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Health Policy  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Ronald Bayer, PhD

Arch Intern Med. 1999;159:1042-1048.

In the 18 years since the first cases of the acquired immunodeficiency syndrome (AIDS) were reported by the Centers for Disease Control and Prevention (CDC), the epidemic has undergone profound transformations, and so, too, has the sociomedical context within which public health policy is fashioned and implemented. The early years of neglect and panic were also characterized by relative therapeutic impotence and deep uncertainty about the epidemiological course the new threat would take. In the United States and in other economically advanced nations, the threat of contracting the human immunodeficiency virus (HIV) has abated. The incidence of infection has declined, and the prevalence of infection has stabilized and, in some instances, begun to fall. The pattern of HIV spread, where it has continued, has been dramatically circumscribed to marginalized populations.¹ The panic of the mid-1980s has passed, and in many nations, AIDS has lost its salience as a public issue. A sense of therapeutic impotence no longer prevails, and a new mood of triumphalism has taken hold. How have these crucial changes affected AIDS policies in America?

From the Division of Sociomedical Sciences, Columbia University School of Public Health, New York, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV seropositive status disclosure to prospective sex partners and criminal laws that require it: perspectives of persons living with HIV
Galletly and Dickson-Gomez
Int J STD AIDS 2009;20:613-618.
ABSTRACT | FULL TEXT  

Routine HIV Testing in Dental Practice: Can We Cross the Rubicon?
Vernillo and Caplan
J Dent Educ 2007;71:1534-1539.
ABSTRACT | FULL TEXT  

HIV exceptionalism, CD4+ cell testing, and conscientious subversion
Jansen
J. Med. Ethics 2005;31:322-326.
ABSTRACT | FULL TEXT  

HIV-Related Stigma and Knowledge in the United States: Prevalence and Trends, 1991-1999
Herek et al.
AJPH 2002;92:371-377.
ABSTRACT | FULL TEXT  

Genetic Exceptionalism vs. Paradigm Shift: Lessons from HIV
Ross
J Law Med Ethics 2001;29:141-148.
 

What Lessons Can We Learn from the Exceptionalism Debate (Finally)?
Lazzarini
J Law Med Ethics 2001;29:149-151.
 

Genetic Exceptionalism vs. Paradigm Shift: Lessons from HIV
Ross
J Law Med Ethics 2001;29:141-148.
 

What Lessons Can We Learn from the Exceptionalism Debate (Finally)?
Lazzarini
J Law Med Ethics 2001;29:149-151.